发明申请
- 专利标题： METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TH17 MEDIATED DISEASES
-
申请号： US15568205申请日： 2016-04-21
-
公开(公告)号： US20180298104A1公开(公告)日： 2018-10-18
- 发明人: Patrick LEGEMBRE , Patrick BLANCO , Robin FLYNN
- 申请人： INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) , UNIVERSITY OF NOTTINGHAM , UNIVERSITE DE BORDEAUX , CHU HOPITAUX DE BORDEAUX , UNIVERSITE DE RENNES , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE(CNRS)
- 优先权： EP15305606.4 20150422
- 国际申请： PCT/EP2016/058838 WO 20160421
- 主分类号： C07K16/28
- IPC分类号： C07K16/28 ; C12N15/115 ; C12N15/113
摘要：
The present invention relates to methods and pharmaceutical compositions for the treatment of Th17-mediated diseases. In particular, the present invention relates to a method of treating a Th17-mediated disease in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a CD95 antagonist.
信息查询
